391 related articles for article (PubMed ID: 29304196)
1. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
[TBL] [Abstract][Full Text] [Related]
2. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
[TBL] [Abstract][Full Text] [Related]
3. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
4. Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Verschoor EJ; Fagrouch ZC; Kondova I; Boonstra A; Koopman G
J Gen Virol; 2016 Oct; 97(10):2599-2607. PubMed ID: 27534537
[TBL] [Abstract][Full Text] [Related]
5. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
6. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
7. HIV and hepatitis C coinfection: pathogenesis and microbial translocation.
Page EE; Nelson M; Kelleher P
Curr Opin HIV AIDS; 2011 Nov; 6(6):472-7. PubMed ID: 21918438
[TBL] [Abstract][Full Text] [Related]
8. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.
Jenabian MA; Mehraj V; Costiniuk CT; Vyboh K; Kema I; Rollet K; Paulino Ramirez R; Klein MB; Routy JP
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):254-62. PubMed ID: 26436613
[TBL] [Abstract][Full Text] [Related]
9. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
Bailony MR; Scherzer R; Huhn G; Plankey MW; Peters MG; Tien PC
J Infect Dis; 2013 Dec; 208(11):1776-83. PubMed ID: 23901097
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
[TBL] [Abstract][Full Text] [Related]
12. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.
Márquez M; Romero-Cores P; Montes-Oca M; Martín-Aspas A; Soto-Cárdenas MJ; Guerrero F; Fernández-Gutiérrez C; Girón-González JA
PLoS One; 2015; 10(3):e0119568. PubMed ID: 25775475
[TBL] [Abstract][Full Text] [Related]
13. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.
Bierhoff E; Fischer HP; Willsch E; Rockstroh J; Spengler U; Brackmann HH; Oldenburg J
Virchows Arch; 1997 Apr; 430(4):271-7. PubMed ID: 9134037
[TBL] [Abstract][Full Text] [Related]
14. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
[TBL] [Abstract][Full Text] [Related]
15. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
16. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity.
Feuth T; Van Baarle D; Hoepelman AI; Van Erpecum KJ; Siersema PD; Arends JE
Apoptosis; 2014 Jul; 19(7):1128-35. PubMed ID: 24752774
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
[TBL] [Abstract][Full Text] [Related]
19. [Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus].
Shmagel KV; Shmagel NG; Korolevskaya LB; Saydakova EV; Chereshnev VA
Ter Arkh; 2016; 88(11):22-28. PubMed ID: 28005028
[TBL] [Abstract][Full Text] [Related]
20. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
